With the agreement, Pfizer, one of the top makers of Covid-19 vaccines, acquires GBT's Oxbryta to treat the potentially fatal blood disorder that primarily affects people of African, Middle Eastern or South Asian descent.
from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/e5SW2Mv
No comments:
Post a Comment